DELIVERING SUSTAINED GROWTH

We are diligently and sustainably achieving
excellence in all that we do
  • JV between APL and Shanxi Tongling Pharmaceuticals launched under the name Aurobindo Tongling (Datong) pharmaceuticals Ltd China
  • APL’s 100% subsidiary company in China commenced commercial production
  • Aurobindo received its first Certificate of Suitability (CoS) approval from the European Directorate for Quality Medicines (EDQM)